Consolidated figures · ₹ crore
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 183 | 214 | 235 | 266 | 305 | 311 | 333 | |
| COGS | 20 | 50 | 63 | 77 | 96 | 88 | 82 |
| Gross profit | 164 | 164 | 172 | 189 | 209 | 223 | 251 |
| 108 | 95 | 112 | 134 | 150 | 158 | 158 | |
| 55 | 69 | 60 | 55 | 58 | 65 | 93 | |
| OPM % | 30.2% | 32% | 25.7% | 20.7% | 19.1% | 20.9% | 28% |
| Depreciation | 13 | 13 | 17 | 21 | 17 | 17 | 19 |
| Interest | 7 | 7 | 4 | 9 | 20 | 13 | 11 |
| 6 | 1 | 14 | 15 | 11 | 4 | 13 | |
| Profit before tax | 41 | 50 | 54 | 40 | 32 | 40 | 76 |
| Tax | 10 | 15 | 14 | 12 | 11 | 11 | 18 |
| Tax % | 25% | 30.8% | 26.2% | 30.2% | 33.8% | 27.2% | 24.2% |
| 31 | 35 | 39 | 28 | 21 | 29 | 57 | |
| PAT margin % | 16.9% | 16.2% | 16.8% | 10.5% | 7% | 9.3% | 17.3% |
| EPS (₹) | 36.4 | 40.8 | 46.4 | 33 | 24.9 | 33.9 | 67.6 |
| EPS adjusted (₹) | 34.3 | 40.5 | 46.2 | 31.3 | 22.2 | 32.3 | 65.4 |
| 18.1% | 24.5% | 21.5% | 24.3% | 24.1% | 20.7% | 16.3% | |
| Annual report | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | — | 193 | 220 | 251 | 271 | 283 | 306 | 352 |
| Minority interest | — | 5 | 8 | 7 | 9 | 11 | 12 | 8 |
| — | 109 | 105 | 223 | 268 | 239 | 208 | 188 | |
| — | 71 | 71 | 72 | 113 | 120 | 119 | 122 | |
| Total equity & liabilities | — | 387 | 411 | 562 | 670 | 662 | 653 | 678 |
| 145 | 142 | 133 | 237 | 259 | 240 | 233 | 411 | |
| CWIP | — | 74 | 109 | 80 | 146 | 168 | 177 | — |
| Investments | — | 0 | 0 | 21 | 25 | 30 | 34 | 43 |
| — | 170 | 170 | 224 | 239 | 224 | 209 | 224 | |
| Total assets | — | 387 | 411 | 562 | 670 | 662 | 653 | 678 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Poultry Healthcare | 205.97 | 58.09 | 123.36 | 15.8 | 107.56 | 54.01 |
| Animal Healthcare | 126.63 | 25.27 |
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 37 | 58 | 9 | 24 | 48 | 65 | 64 | |
| -74 | -38 | -117 | -77 | -23 | -19 | -3 | |
| 19 | -18 | 112 | 42 | -26 | -52 | -49 | |
| Net cash flow | -19 | 1 | 4 | -12 | -1 | -6 | 12 |
| Free cash flow | -37 | 17 | -87 | -54 | 24 | 44 | 46 |
| CFO / Operating profit % | 66.4% | 84.5% | 14.7% | 46.6% | 89.7% | 105.7% | 74% |
| 225.39 |
| 23.32 |
| 202.07 |
| 12.51 |
₹ crore by fiscal year